FILARIASIS OUTLINE WHAT IS FILARIASIS

Similar documents
Department of Epidemiological Surveillance and Intervention

PART B: Water-associates vector-borne diseases, with the emphasis on the vector

LYMPHATIC FILARIASIS WORLD HEALTH ORGANIZATION GLOBAL PROGRAMME TO ELIMINATE LYMPHATIC FILARIASIS

A global brief on vector-borne diseases

Resolving the Critical Challenges Now Facing the Global Programme to Eliminate Lymphatic Filariasis

Zika Virus. History of Zika virus

Saint Louis Encephalitis (SLE)

Saint Louis Encephalitis (SLE)

Principles of Disease and Epidemiology. Copyright 2010 Pearson Education, Inc.

Borderless Diseases By Sunny Thai

Laboratory Diagnosis of Infections Due to Blood and Tissue Parasites

William C. Campbell and Satoshi Ōmura for their discoveries concerning a novel therapy against infections caused by roundworm parasites

CURRICULUM VITAE. TANGA MBI CHRYSANTUS Date of birth: 05 th August 1977 Limbe, Fako Division, South West Province

Malaria in the WHO EurOpEan region

Multiple Choice Questions

The global classroom: Training the world s healthcare professionals

Frequently asked questions for malaria

WHY IS THIS IMPORTANT?

Drug-resistant Tuberculosis

Blood Cells. Morphology & Clinical Relevance. 2nd edition

Institute for OneWorld Health


Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges

Approaches to Infection Control

Viral Hepatitis A, B, and C

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

Fact Sheet for Health Care Providers: Interpreting Results from the Aptima Zika Virus Assay. June 17, 2016

PUBLIC HEALTH PARASITOLOGY PHC 6513 Syllabus, Spring Semester 2014

MOBILE MEDICAL APPLICATIONS

Ch 14: Principles of Disease and Epidemiology

How To Kill Jesuva

You are planning to travel on vacation or business does your destination require a vaccination?

TB CARE EARLY DETECTION AND PREVENTION OF TUBERCULOSIS (TB) IN CHILDREN. Risk factors in children acquiring TB:

Establishing a Global Campaign for Combating Cysticercosis: An Opportunity for Improving Human Health and Livestock Production in Developing Countries

Date of Commencement: January, 2004 Duration: One Year Status: Ongoing. Objectives

ABSTRACTS. This meeting was made possible by support from the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases

Plan early - get your vaccinations in time for full protection. To prepare for your trip, schedule an appointment: (910) , option #2.

It takes a planet: global implications/consequences of local vaccine refusal

PERTUSSIS SURVEILLANCE AND RESPONSE PROTOCOL

The Global Alliance against Chronic Respiratory Diseases

Seroprevalence and risk factors of Lassa fever infection in Nasarawa State, Nigeria 2013

Gail Bennett, RN, MSN, CIC

Guidance Document Infectious Substances

M&E Strategies for a Community IRS Program

The Case of Ivermectin: Lessons Learned and Implications for Improving Access to Care and Treatment in Developing Countries

Program in Public Health Course Descriptions

Sentinel Chicken Screening Here are the mosquito larvae! Ground Application Aerial Larvicide Applications

Targeted Testing for Tuberculosis Infection

Maria Dalbey RN. BSN, MA, MBA March 17 th, 2015

WOOD COUNTY SCHOOL OF PRACTICAL NURSING. Medical/Surgical Nursing: Reproductive

CHAPTER 1 Mosquitos and other biting Diptera

APPENDIX A GUIDANCE DOCUMENT

GIEMSA STAIN PREANALYTICAL CONSIDERATIONS

DENGUE FEVER. This article was prepared to provide more information about Dengue Fever and Dengue Hemorrhagic Fever

The Impact of HIV/AIDS on the South African Mining Industry

E. Russell, E. Hiby, F. Abson

CHAPTER 35 HUMAN IMMUNE SYSTEM STANDARDS:SC.912.L & SC.912.L.14.6

Course Descriptions. I. Professional Courses: MSEG 7216: Introduction to Infectious Diseases (Medical Students)

The link between cervical cancer and HPV (human papillomavirus)

Frequently Asked Questions (FAQs)

The Hepatitis B virus (HBV)

SCHISTOSOMIASIS PEDIATRIC PRAZIQUANTEL CONSORTIUM. Treating preschool children

Chapter 8 Community Tuberculosis Control

WEST NILE VIRUS DEPARTMENT OF HEALTH AND HUMAN SERVICES

Lesson 1 Understanding the Epidemiologic Triangle through Infectious Disease

Shutterstock TACstock

BACKGROUND MEDIA INFORMATION Fast facts about liver disease

U.S. President s Malaria Initiative (PMI) Approach to Health Systems Strengthening

Disease surveillance and outbreak prevention and control

KEY CONCEPT Organisms can be classified based on physical similarities. binomial nomenclature

EBOLA RESPONSE ROADMAP ROADMAP SITUATION REPORT

SAULT COLLEGE OF APPLIED ARTS AND TECHNOLOGY SAULT STE. MARIE, ONTARIO COURSE OUTLINE

10. Vector and pest control

Personal Injury TYPES OF HOLIDAY ILLNESSES. Telephone

SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item May Hepatitis

Course Outline and Syllabus for Students

PUBLIC HEALTH PROGRAM

Scaling up diagnostic testing, treatment and surveillance for malaria

Transcription:

FILARIASIS By Micaela Yanez OUTLINE Introduction of Filariasis History Transmission Epidemiology Progress of Lymphatic Filariasis The Disease Symptoms and Treatments WHAT IS FILARIASIS A disease that affects humans and animals and is caused by nematode parasites of the order Filariidae. Of the 100 described filarial parasites only 8 species cause infection in humans. The 8 filarial parasites are classified by the location they inhabit in host

CLASSIFICATION OF FILARIAL PARASITES 1 st group- Cutaneous (of the skin) Loa loa Onchocerca volvulus Mansonella streptocerca 2 nd group- Lymphatic (Lymphatic system) Wuchereria bancrofti Brugia malayi Brugia timori 3 rd group- Body Cavity Mansonella perstans Mansonella Ozzardi LYMPHATIC FILARIASIS "a parasitic disease caused by threadlike worms living in the human lymphatic system." The "threadlike worm" that can cause lymphatic filariasis is a blood-dwelling filarial nematode, from the aschelminth phyla 3 known species: Wuchereria bancrofti Brugia malayi Brugia timori WHAT ARE THE DIFFERENCE? Differences between W. bancrofti, B. malayi and B. timori reside in epidemiology, vectors, reservoirs, symptoms, but mainly species morphology.

WUCHERERIA BANCROFTI well-documented most widespread cause of lymphatic filariasis morphologically significantly different from the other species Wuchereria bancrofti in a blood smear BRUGIA MALAYI Vector and reservoir Transmitted by Mansonia mosquitos Animal reservoirs Morphology differences BRUGIA TIMORI Least common Least studied More similar to W. bancrofti that to B. malayi Vector Anopheles barbirostris No known animal reservoirs Symptoms and morphology resembles B. malayi Larger then B. malayi

HISTORY OF LYMPHATIC FILARIASIS Timeline of discovery 2000BC Pharaoh Mentuhotep II 500 AD Nok civilization in West Africa Greek and Roman civilization 1588-1592 symptoms 1849- symptoms 1863 and 1866- microfilariae 1876- adult worm 1877- life cycle 1900- transmission TRANSMISSION A wide range of mosquitoes can transmit the parasite, depending on the geographic area. In Africa, the most common vector is Anopheles In the Americas, it is Culex quinquefasciatus, and Aedes Mansonia can transmit the infection in the Pacific and in Asia. Anopheles Mansonia titillans Culex quinquefasciatus Aedes TRANSMISSION

EPIDEMIOLOGY Endemic in approx. 80 countries 120 million infected 40 million seriously incapacitated or disfigured India, Indonesia, Nigeria, & Bangladesh =70% 1/3 of infected live in India 1/3 of infected live in Africa Remainder are in South Asia, the Pacific and South America EPIDEMIOLOGY Most of the infections worldwide are caused by Wuchereria bancrofti. In Asia, the disease can also be caused by Brugia malayi and Brugia timori. Microfilaria of Wuchereria bancrofti, top image. Microfilaria of Brugia malayi, bottom image. (CDC Photos; DPDx)

PROGRESSION OF LYMPHATIC FILARIASIS 3 STAGES OF PROGRESSION * Prepatent Period * Incubation Period * Chronic Stage of Lymphatic Filariasis Adult W. bancrofti worms with the smaller male on the left and larger female on the right THE DISEASE Elephantiasis The individuals above are all infected with W. bancrofti. DIAGNOSIS ICT Test X-Ray Detection Blood Test

PREVENTION AND TREATMENT there is no known vaccine or cure for lymphatic filariasis Diethylcarbamazine (DEC) is a popular microfilaricide, and has been used in Mass Drug Treatment programs. symptoms are often treated with antihistamines, and antibiotics ERADICATION Lymphatic filariasis is one of seven diseases worldwide that the WHO has targeted for eradication Global Alliance to Eliminate Lymphatic Filariasis REVIEW What is filariasis How its transmitted Where its found The disease Treatment, Prevention, and Eradication

REFERENCES Center for Disease Control and Prevention. 2007. Lymphatic Filariasis. Accessed online at http://www.cdc.gov/ncidod/dpd/parasites/lymphaticfilariasis/ Dreyer, G., Noroes, J., Figueredo-Silva, J., and Piessens, W.F. 2000. Pathogenesis of Lymphatic Disease in Bancroftian Filariasis: A clinical Perspective. Parasitology Today. 16:545-550. John, David T. and William A. Petri Jr. "Brugia malayi." Medical Parasitology. 9th ed. St. Louis, Missouri: Saunders Elsevier, 2006. 285-289. John, David T. and William A. Petri Jr. "Wuchereria bancrofti." Medical Parasitology. 9th ed. St. Louis, Missouri: Saunders Elsevier, 2006. 274-285. John, David T. and William A. Petri Jr. "Wuchereria bancrofti." Medical Parasitology. 9th ed. St. Louis, Missouri: Saunders Elsevier, 2006. 274-285. John, David T. and William A. Petri Jr. "Brugia timori." Medical Parasitology. 9th ed. St. Louis, Missouri: Saunders Elsevier, 2006. 287-289. Melrose, Wayne D. 2002. Lymphatic filariasis: new insights into an old disease. International Journal of Parasitology. 32:947/960. The Global Alliance to Eliminate Lymphatic Filariasis. Accessed April 2009 at http://www.filariasis.org/.